Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition)
- PMID:17873163
- DOI: 10.1378/chest.07-1352
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition)
Abstract
Background: The solitary pulmonary nodule (SPN) is a frequent incidental finding that may represent primary lung cancer or other malignant or benign lesions. The optimal management of the SPN remains unclear.
Methods: We conducted a systematic literature review to address the following questions: (1) the prevalence of SPN; (2) the prevalence of malignancy in nodules with varying characteristics (size, morphology, and type of opacity); (3) the relationships between growth rates, histology, and other nodule characteristics; and (4) the performance characteristics and complication rates of tests for SPN diagnosis. We searched MEDLINE and other databases and used previous systematic reviews and recent primary studies.
Results: Eight large trials of lung cancer screening showed that both the prevalence of at least one nodule (8 to 51%) and the prevalence of malignancy in patients with nodules (1.1 to 12%) varied considerably across studies. The prevalence of malignancy varied by size (0 to 1% for nodules < 5 mm, 6 to 28% for nodules 5 to 10 mm, and 64 to 82% for nodules > 20 mm). Data from six studies of patients with incidental or screening-detected nodules showed that the risk for malignancy was approximately 20 to 30% in nodules with smooth edges; in nodules with irregular, lobulated, or spiculated borders, the rate of malignancy was higher but varied across studies from 33 to 100%. Nodules that were pure ground-glass opacities were more likely to be malignant (59 to 73%) than solid nodules (7 to 9%). The sensitivity of positron emission tomography imaging for identifying a malignant SPN was consistently high (80 to 100%), whereas specificity was lower and more variable across studies (40 to 100%). Dynamic CT with nodule enhancement yielded the most promising sensitivity (sensitivity, 98 to 100%; specificity, 54 to 93%) among imaging tests. In studies of CT-guided needle biopsy, nondiagnostic results were seen approximately 20% of the time, but sensitivity and specificity were excellent when biopsy yielded a specific benign or malignant result.
Conclusions: The prevalence of an SPN and the prevalence of malignancy in patients with an SPN vary widely across studies. The interpretation of these variable prevalence rates should take into consideration not only the nodule characteristics but also the population at risk. Modern imaging tests and CT-guided needle biopsy are highly sensitive for identifying a malignant SPN, but the specificity of imaging tests is variable and often poor.
Similar articles
- Evaluating the Patient With a Pulmonary Nodule: A Review.Mazzone PJ, Lam L.Mazzone PJ, et al.JAMA. 2022 Jan 18;327(3):264-273. doi: 10.1001/jama.2021.24287.JAMA. 2022.PMID:35040882Review.
- Management of solitary pulmonary nodules.Lillington GA.Lillington GA.Dis Mon. 1991 May;37(5):271-318. doi: 10.1016/s0011-5029(05)80012-4.Dis Mon. 1991.PMID:2019220Review.
- Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).Gould MK, Fletcher J, Iannettoni MD, Lynch WR, Midthun DE, Naidich DP, Ost DE; American College of Chest Physicians.Gould MK, et al.Chest. 2007 Sep;132(3 Suppl):108S-130S. doi: 10.1378/chest.07-1353.Chest. 2007.PMID:17873164
- Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling.Gilbert FJ, Harris S, Miles KA, Weir-McCall JR, Qureshi NR, Rintoul RC, Dizdarevic S, Pike L, Sinclair D, Shah A, Eaton R, Clegg A, Benedetto V, Hill JE, Cook A, Tzelis D, Vale L, Brindle L, Madden J, Cozens K, Little LA, Eichhorst K, Moate P, McClement C, Peebles C, Banerjee A, Han S, Poon FW, Groves AM, Kurban L, Frew AJ, Callister ME, Crosbie P, Gleeson FV, Karunasaagarar K, Kankam O, George S.Gilbert FJ, et al.Health Technol Assess. 2022 Mar;26(17):1-180. doi: 10.3310/WCEI8321.Health Technol Assess. 2022.PMID:35289267Clinical Trial.
- Update in the evaluation of the solitary pulmonary nodule.Truong MT, Ko JP, Rossi SE, Rossi I, Viswanathan C, Bruzzi JF, Marom EM, Erasmus JJ.Truong MT, et al.Radiographics. 2014 Oct;34(6):1658-79. doi: 10.1148/rg.346130092.Radiographics. 2014.PMID:25310422Review.
Cited by
- (18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.van Gómez López O, García Vicente AM, Honguero Martínez AF, Jiménez Londoño GA, Vega Caicedo CH, León Atance P, Soriano Castrejón ÁM.van Gómez López O, et al.Transl Lung Cancer Res. 2015 Jun;4(3):228-35. doi: 10.3978/j.issn.2218-6751.2015.05.07.Transl Lung Cancer Res. 2015.PMID:26207210Free PMC article.
- Incidental Pulmonary Nodules - What Do We Know in 2022.Schmid-Bindert G, Vogel-Claussen J, Gütz S, Fink J, Hoffmann H, Eichhorn ME, Herth FJF.Schmid-Bindert G, et al.Respiration. 2022;101(11):1024-1034. doi: 10.1159/000526818. Epub 2022 Oct 13.Respiration. 2022.PMID:36228594Free PMC article.Review.
- Multi-model Ensemble Learning Architecture Based on 3D CNN for Lung Nodule Malignancy Suspiciousness Classification.Liu H, Cao H, Song E, Ma G, Xu X, Jin R, Liu C, Hung CC.Liu H, et al.J Digit Imaging. 2020 Oct;33(5):1242-1256. doi: 10.1007/s10278-020-00372-8.J Digit Imaging. 2020.PMID:32607905Free PMC article.
- Computed tomography-guided preoperative semi-rigid hook-wire localization of small pulmonary nodules: 74 cases report.Zhao G, Yu X, Chen W, Geng G, Li N, Liu H, Yin P, Sun L, Jiang J.Zhao G, et al.J Cardiothorac Surg. 2019 Aug 19;14(1):149. doi: 10.1186/s13019-019-0958-z.J Cardiothorac Surg. 2019.PMID:31426812Free PMC article.
- Detection of solid and subsolid pulmonary nodules with lung MRI: performance of UTE, T1 gradient-echo, and single-shot T2 fast spin echo.Sanchez F, Tyrrell PN, Cheung P, Heyn C, Graham S, Poon I, Ung Y, Louie A, Tsao M, Oikonomou A.Sanchez F, et al.Cancer Imaging. 2023 Feb 16;23(1):17. doi: 10.1186/s40644-023-00531-4.Cancer Imaging. 2023.PMID:36793094Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources